Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 227

1.

Statins are independently associated with reduced mortality in patients undergoing infrainguinal bypass graft surgery for critical limb ischemia.

Schanzer A, Hevelone N, Owens CD, Beckman JA, Belkin M, Conte MS.

J Vasc Surg. 2008 Apr;47(4):774-781. doi: 10.1016/j.jvs.2007.11.056.

2.

Patients undergoing infrainguinal bypass to treat atherosclerotic vascular disease are underprescribed cardioprotective medications: effect on graft patency, limb salvage, and mortality.

Henke PK, Blackburn S, Proctor MC, Stevens J, Mukherjee D, Rajagopalin S, Upchurch GR Jr, Stanley JC, Eagle KA.

J Vasc Surg. 2004 Feb;39(2):357-65.

4.

Risk factors, medical therapies and perioperative events in limb salvage surgery: observations from the PREVENT III multicenter trial.

Conte MS, Bandyk DF, Clowes AW, Moneta GL, Namini H, Seely L.

J Vasc Surg. 2005 Sep;42(3):456-64; discussion 464-5.

5.

Disparity in outcomes of surgical revascularization for limb salvage: race and gender are synergistic determinants of vein graft failure and limb loss.

Nguyen LL, Hevelone N, Rogers SO, Bandyk DF, Clowes AW, Moneta GL, Lipsitz S, Conte MS.

Circulation. 2009 Jan 6;119(1):123-30. doi: 10.1161/CIRCULATIONAHA.108.810341. Epub 2008 Dec 22.

6.

Statin therapy is associated with superior clinical outcomes after endovascular treatment of critical limb ischemia.

Aiello FA, Khan AA, Meltzer AJ, Gallagher KA, McKinsey JF, Schneider DB.

J Vasc Surg. 2012 Feb;55(2):371-9; discussion 380. doi: 10.1016/j.jvs.2011.08.044. Epub 2011 Nov 1.

7.

Statin therapy after infrainguinal bypass surgery for critical limb ischemia is associated with improved 5-year survival.

Suckow BD, Kraiss LW, Schanzer A, Stone DH, Kalish J, DeMartino RR, Cronenwett JL, Goodney PP; Vascular Study Group of New England.

J Vasc Surg. 2015 Jan;61(1):126-33. doi: 10.1016/j.jvs.2014.05.093. Epub 2014 Jul 16.

8.

Preoperative statin therapy is associated with reduced cardiac mortality after coronary artery bypass graft surgery.

Collard CD, Body SC, Shernan SK, Wang S, Mangano DT; Multicenter Study of Perioperative Ischemia (MCSPI) Research Group, Inc; Ischemia Research and Education Foundation (IREF) Investigators.

J Thorac Cardiovasc Surg. 2006 Aug;132(2):392-400.

9.

Surgical and endovascular revision of infrainguinal vein bypass grafts: analysis of midterm outcomes from the PREVENT III trial.

Berceli SA, Hevelone ND, Lipsitz SR, Bandyk DF, Clowes AW, Moneta GL, Conte MS.

J Vasc Surg. 2007 Dec;46(6):1173-1179. Epub 2007 Oct 22.

10.

Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery.

Conte MS, Bandyk DF, Clowes AW, Moneta GL, Seely L, Lorenz TJ, Namini H, Hamdan AD, Roddy SP, Belkin M, Berceli SA, DeMasi RJ, Samson RH, Berman SS; PREVENT III Investigators.

J Vasc Surg. 2006 Apr;43(4):742-751; discussion 751.

11.

Comparative analysis of autogenous infrainguinal bypass grafts in African Americans and Caucasians: the association of race with graft function and limb salvage.

Chew DK, Nguyen LL, Owens CD, Conte MS, Whittemore AD, Gravereaux EC, Menard MT, Belkin M.

J Vasc Surg. 2005 Oct;42(4):695-701.

12.

Outcomes associated with the use of secondary prevention medications after coronary artery bypass graft surgery.

Goyal A, Alexander JH, Hafley GE, Graham SH, Mehta RH, Mack MJ, Wolf RK, Cohn LH, Kouchoukos NT, Harrington RA, Gennevois D, Gibson CM, Califf RM, Ferguson TB Jr, Peterson ED; PREVENT IV Investigators.

Ann Thorac Surg. 2007 Mar;83(3):993-1001.

PMID:
17307447
13.

One-year prospective quality-of-life outcomes in patients treated with angioplasty for symptomatic peripheral arterial disease.

Kalbaugh CA, Taylor SM, Blackhurst DW, Dellinger MB, Trent EA, Youkey JR.

J Vasc Surg. 2006 Aug;44(2):296-302; discussion 302-3. Epub 2006 Jul 11.

14.

Resource utilization in the treatment of critical limb ischemia: The effect of tissue loss, comorbidities, and graft-related events.

Nguyen LL, Lipsitz SR, Bandyk DF, Clowes AW, Moneta GL, Belkin M, Conte MS.

J Vasc Surg. 2006 Nov;44(5):971-5; discussion 975-6.

15.

Association between statin therapy and amputation-free survival in patients with critical limb ischemia in the CRITISCH registry.

Stavroulakis K, Borowski M, Torsello G, Bisdas T; CRITISCH collaborators.

J Vasc Surg. 2017 Nov;66(5):1534-1542. doi: 10.1016/j.jvs.2017.05.115. Epub 2017 Aug 12.

PMID:
28807382
16.

A multicenter comparison between autologous saphenous vein and heparin-bonded expanded polytetrafluoroethylene (ePTFE) graft in the treatment of critical limb ischemia in diabetics.

Dorigo W, Pulli R, Castelli P, Dorrucci V, Ferilli F, De Blasis G, Monaca V, Vecchiati E, Pratesi C; Propaten Italian Registry Group.

J Vasc Surg. 2011 Nov;54(5):1332-8. doi: 10.1016/j.jvs.2011.05.046. Epub 2011 Aug 15.

17.

Postoperative outcomes for patients undergoing elective revascularization for critical limb ischemia and intermittent claudication: a subanalysis of the Coronary Artery Revascularization Prophylaxis (CARP) trial.

Raghunathan A, Rapp JH, Littooy F, Santilli S, Krupski WC, Ward HB, Thottapurathu L, Moritz T, McFalls EO; CARP Investigators.

J Vasc Surg. 2006 Jun;43(6):1175-82.

18.

Wound healing and functional outcomes after infrainguinal bypass with reversed saphenous vein for critical limb ischemia.

Chung J, Bartelson BB, Hiatt WR, Peyton BD, McLafferty RB, Hopley CW, Salter KD, Nehler MR.

J Vasc Surg. 2006 Jun;43(6):1183-90.

19.

Completion duplex ultrasound predicts early graft thrombosis after crural bypass in patients with critical limb ischemia.

Scali ST, Beck AW, Nolan BW, Stone DH, De Martino RR, Chang CK, Rzucidlo EM, Walsh DB.

J Vasc Surg. 2011 Oct;54(4):1006-10. doi: 10.1016/j.jvs.2011.04.021. Epub 2011 Aug 6.

20.

Reoperative lower extremity revascularization with cadaver vein for limb salvage.

Bannazadeh M, Sarac TP, Bena J, Srivastava S, Ouriel K, Clair D.

Ann Vasc Surg. 2009 Jan-Feb;23(1):24-31. doi: 10.1016/j.avsg.2008.04.011. Epub 2008 Jul 26.

PMID:
18657383

Supplemental Content

Support Center